Neuen BL, Fletcher RA, Heath L, Perkovic A, et al. Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
PMID: 39210781